Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
McKesson
AstraZeneca
Johnson and Johnson
Harvard Business School

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Apotex Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for APOTEX, and what generic and branded alternatives to APOTEX drugs are available?

APOTEX has two hundred and seventy-six approved drugs.

There are twenty-five tentative approvals on APOTEX drugs.

Drugs and US Patents for Apotex

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 076706-001 Dec 14, 2004 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Apotex Inc ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 090548-001 May 29, 2012 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Apotex Inc MELOXICAM meloxicam TABLET;ORAL 077882-002 Jul 20, 2006 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Apotex DIVALPROEX SODIUM divalproex sodium TABLET, DELAYED RELEASE;ORAL 077615-002 Jul 29, 2008 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Apotex Inc DOCETAXEL docetaxel INJECTABLE;INJECTION 022312-001 Jan 11, 2012 DISCN No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Apotex

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apotex Technologies PAXIL paroxetine hydrochloride SUSPENSION;ORAL 020710-001 Jun 25, 1997 5,811,436*PED ⤷  Sign up for a Free Trial
Apotex Technologies PAXIL paroxetine hydrochloride CAPSULE;ORAL 020885-004 Oct 9, 1998 6,080,759*PED ⤷  Sign up for a Free Trial
Apotex Technologies PAXIL paroxetine hydrochloride CAPSULE;ORAL 020885-003 Oct 9, 1998 5,872,132*PED ⤷  Sign up for a Free Trial
Apotex Technologies PAXIL CR paroxetine hydrochloride TABLET, EXTENDED RELEASE;ORAL 020936-003 Dec 6, 2000 6,080,759*PED ⤷  Sign up for a Free Trial
Apotex Technologies PAXIL CR paroxetine hydrochloride TABLET, EXTENDED RELEASE;ORAL 020936-003 Dec 6, 2000 7,229,640*PED ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for APOTEX drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Oral Suspension 10 mg/5 mL ➤ Subscribe 2005-02-10
➤ Subscribe Extended-release Tablets 37.5 mg ➤ Subscribe 2009-05-19
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
➤ Subscribe Extended-release Tablets 25 mg ➤ Subscribe 2005-09-09
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Medtronic
McKinsey
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.